{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:11:18Z","timestamp":1793412678781,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T00:00:00Z","timestamp":1427500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s10238-015-0345-6","type":"journal-article","created":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T22:00:07Z","timestamp":1427580007000},"page":"125-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Autoimmune uveitis: clinical, pathogenetic, and therapeutic features"],"prefix":"10.1007","volume":"16","author":[{"given":"Marcella","family":"Prete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Dammacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Celeste","family":"Fatone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"key":"345_CR1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"DC Gritz","year":"2004","unstructured":"Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of uveitis study. Ophthalmology. 2004;111:491\u2013500.","journal-title":"Ophthalmology"},{"issue":"4","key":"345_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12348-014-0017-9","volume":"24","author":"M Prete","year":"2014","unstructured":"Prete M, Guerriero S, Dammacco R, Fatone MC, Vacca A, Dammacco F, Racanelli V. Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center. J Ophthalmic Inflamm Infect. 2014;24(4):17. doi: 10.1186\/s12348-014-0017-9 .","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"345_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/09273940600732372","volume":"14","author":"M Khairallah","year":"2006","unstructured":"Khairallah M, Attia S, Zaouali S, et al. Pattern of childhood-onset uveitis in a referral center in Tunisia, North Africa. Ocul Immunol Inflamm. 2006;14:225\u201331.","journal-title":"Ocul Immunol Inflamm"},{"key":"345_CR4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1755-3768.2008.01282.x","volume":"87","author":"H Kitamei","year":"2009","unstructured":"Kitamei H, Kitaichi N, Namba K, Kotake S. Goda: clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmol. 2009;87:424\u20138.","journal-title":"Acta Ophthalmol"},{"key":"345_CR5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1442-9071.2009.02102.x","volume":"37","author":"H Keino","year":"2009","unstructured":"Keino H, Nakashima C, Watanabe T, et al. Frequency and clinical features of intraocular inflammation in Tokyo. Clin Exp Ophthalmol. 2009;37:595\u2013601.","journal-title":"Clin Exp Ophthalmol"},{"key":"345_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1172-7-57","volume":"7","author":"T Barisani-Asenbauer","year":"2012","unstructured":"Barisani-Asenbauer T, Maca SM, Mejdoubi L, Emminger W, Machold K, Auer H. Uveitis-a rare disease often associated with systemic diseases and infections-a systematic review of 2619 patients. Orphanet J Rare Dis. 2012;7:57.","journal-title":"Orphanet J Rare Dis"},{"key":"345_CR7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/02713680500263606","volume":"30","author":"P Yang","year":"2005","unstructured":"Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943\u20138.","journal-title":"Curr Eye Res"},{"key":"345_CR8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/09273948.2010.502284","volume":"18","author":"HS Al-Mezaine","year":"2010","unstructured":"Al-Mezaine HS, Kangave D, Abu El-Asrar AM. Patterns of uveitis in patients admitted to a University Hospital in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. 2010;18:424\u201331.","journal-title":"Ocul Immunol Inflamm"},{"key":"345_CR9","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","volume":"120","author":"RR Caspi","year":"2010","unstructured":"Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Investig. 2010;120:3073\u201383.","journal-title":"J Clin Investig"},{"key":"345_CR10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.autrev.2010.10.002","volume":"10","author":"AG Commodaro","year":"2011","unstructured":"Commodaro AG, Bueno V, Belfort R Jr, Rizzo LV. Autoimmune uveitis: the associated proinflammatory molecules and the search for immunoregulation. Autoimmun Rev. 2011;10:205\u20139.","journal-title":"Autoimmun Rev"},{"key":"345_CR11","first-page":"329857","volume":"2011","author":"S Guerriero","year":"2011","unstructured":"Guerriero S, Giancipoli E, Ciraci L, et al. Masquerade syndrome of multicentre primary central nervous system lymphoma. Case Rep Ophthalmol Med. 2011;2011:329857.","journal-title":"Case Rep Ophthalmol Med"},{"key":"345_CR12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ajo.2013.11.002","volume":"157","author":"LK Grange","year":"2014","unstructured":"Grange LK, Kouchouk A, Dalal MD, et al. Neoplastic masquerade syndromes in patients with uveitis. Am J Ophthalmol. 2014;157:526\u201331.","journal-title":"Am J Ophthalmol"},{"key":"345_CR13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","volume":"103","author":"E Bloch-Michel","year":"1987","unstructured":"Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234\u20135.","journal-title":"Am J Ophthalmol"},{"key":"345_CR14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"345_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/09273940903348835","volume":"18","author":"M Khairallah","year":"2010","unstructured":"Khairallah M. Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN Working Group classification. Ocul Immunol Inflamm. 2010;18:2\u20134.","journal-title":"Ocul Immunol Inflamm"},{"key":"345_CR16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.autrev.2014.01.006","volume":"13","author":"C Selmi","year":"2014","unstructured":"Selmi C. Diagnosis and classification of autoimmune uveitis. Autoimmun Rev. 2014;13:591\u20134.","journal-title":"Autoimmun Rev"},{"key":"345_CR17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","volume":"32","author":"D Mendes","year":"2009","unstructured":"Mendes D, Correia M, Barbedo M, et al. Behcet\u2019s disease\u2014a contemporary review. J Autoimmun. 2009;32:178\u201388.","journal-title":"J Autoimmun"},{"key":"345_CR18","doi-asserted-by":"crossref","first-page":"A325","DOI":"10.1016\/j.autrev.2009.11.012","volume":"9","author":"M Ehrenfeld","year":"2010","unstructured":"Ehrenfeld M. Geoepidemiology: the environment and spondyloarthropathies. Autoimmun Rev. 2010;9:A325\u20139.","journal-title":"Autoimmun Rev"},{"key":"345_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/RHU.0000000000000087","volume":"20","author":"KM Keck","year":"2014","unstructured":"Keck KM, Choi D, Savage LM, Rosenbaum JT. Insights into uveitis in association with spondyloarthritis from a large patient survey. J Clin Rheumatol. 2014;20:141\u20135.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"345_CR20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/09273948.2013.871565","volume":"22","author":"I Tugal-Tutkun","year":"2014","unstructured":"Tugal-Tutkun I, Quartier P, Bodaghi B. Disease of the year: juvenile idiopathic arthritis-associated uveitis-classification and diagnostic approach. Ocul Immunol Inflamm. 2014;22(1):56\u201363.","journal-title":"Ocul Immunol Inflamm"},{"key":"345_CR21","first-page":"233","volume":"6","author":"EM Nashtaei","year":"2011","unstructured":"Nashtaei EM, Soheilian M, Herbort CP, Yaseri M. Patterns of uveitis in the middle East and Europe. J Ophthalmic Vis Res. 2011;6:233\u201340.","journal-title":"J Ophthalmic Vis Res"},{"key":"345_CR22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/09286580802262821","volume":"15","author":"H Kazokoglu","year":"2008","unstructured":"Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15:285\u201393.","journal-title":"Ophthalmic Epidemiol"},{"key":"345_CR23","doi-asserted-by":"crossref","unstructured":"Kianersi F, Mohammadi Z, Ghanbari H, Ghoreyshi SM, Karimzadeh H, Soheilian M. Clinical patterns of uveitis in an Iranian tertiary eye-care center. Ocul Immunol Inflamm. 16 Apr 2014. (Epub ahead of print).","DOI":"10.3109\/09273948.2014.902474"},{"key":"345_CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11882-013-0409-1","volume":"14","author":"J Pan","year":"2014","unstructured":"Pan J, Kapur M, McCallum R. Noninfectious immune-mediated uveitis and ocular inflammation. Curr Allergy Asthma Rep. 2014;14:409.","journal-title":"Curr Allergy Asthma Rep"},{"key":"345_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/09273948.2011.619295","volume":"19","author":"AP Brezin","year":"2011","unstructured":"Brezin AP, Monnet D, Cohen JH, Levinson RD. HLA-A29 and birdshot chorioretinopathy. Ocul Immunol Inflamm. 2011;19:397\u2013400.","journal-title":"Ocul Immunol Inflamm"},{"key":"345_CR26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9394(82)90069-1","volume":"94","author":"RB Nussenblatt","year":"1982","unstructured":"Nussenblatt RB, Mittal KK, Ryan S, Green WR, Maumenee AE. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 1982;94:147\u201358.","journal-title":"Am J Ophthalmol"},{"key":"345_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08820530500232100","volume":"20","author":"FM Damico","year":"2005","unstructured":"Damico FM, Kiss S, Young LH. Sympathetic ophthalmia. Semin Ophthalmol. 2005;20:191\u20137.","journal-title":"Semin Ophthalmol"},{"key":"345_CR28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/ard.2007.075754","volume":"67","author":"N Zeboulon","year":"2008","unstructured":"Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008;67:955\u20139.","journal-title":"Ann Rheum Dis"},{"key":"345_CR29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.35.4.354","volume":"35","author":"JR Lambert","year":"1976","unstructured":"Lambert JR, Wright V. Eye inflammation in psoriatic arthritis. Ann Rheum Dis. 1976;35:354\u20136.","journal-title":"Ann Rheum Dis"},{"key":"345_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09273941003597268","volume":"18","author":"M Accorinti","year":"2010","unstructured":"Accorinti M, Iannetti L, Liverani M, Caggiano C, Gilardi M. Clinical features and prognosis of HLA B27-associated acute anterior uveitis in an Italian patient population. Ocul Immunol Inflamm. 2010;18:91\u20136.","journal-title":"Ocul Immunol Inflamm"},{"key":"345_CR31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2003.07.011","volume":"111","author":"D Monnet","year":"2004","unstructured":"Monnet D, Breban M, Hudry C, Dougados M, Brezin AP. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology. 2004;111:802\u20139.","journal-title":"Ophthalmology"},{"key":"345_CR32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajo.2010.04.031","volume":"150","author":"AR Loh","year":"2010","unstructured":"Loh AR, Acharya NR. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol. 2010;150:534\u201342.","journal-title":"Am J Ophthalmol"},{"key":"345_CR33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.berh.2008.08.005","volume":"22","author":"S Yurdakul","year":"2008","unstructured":"Yurdakul S, Yazici H. Behcet\u2019s syndrome. Best Pract Res Clin Rheumatol. 2008;22:793\u2013809.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"345_CR34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","volume":"32","author":"D Mendes","year":"2009","unstructured":"Mendes D, Correia M, Barbedo M, et al. Behcet\u2019s disease\u2014a contemporary review. J Autoimmun. 2009;32:178\u201388.","journal-title":"J Autoimmun"},{"key":"345_CR35","doi-asserted-by":"crossref","unstructured":"Foeldvari I. Ocular involvement in juvenile idiopathic arthritis: classification and treatment. Clin Rev Allergy Immunol. 1 Aug 2014. (Epub ahead of print).","DOI":"10.1007\/s12016-014-8436-9"},{"issue":"3","key":"345_CR36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.20945","volume":"52","author":"A Ravelli","year":"2005","unstructured":"Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, Viola S, Martini A. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum. 2005;52(3):826\u201332.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"345_CR37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","volume":"120","author":"AC Gregory 2nd","year":"2013","unstructured":"Gregory AC 2nd, Kempen JH, Daniel E, Ka\u00e7maz RO, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group: risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013;120(1):186\u201392.","journal-title":"Ophthalmology"},{"issue":"5","key":"345_CR38","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajo.2007.01.033","volume":"143","author":"JE Thorne","year":"2007","unstructured":"Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143(5):840\u20136.","journal-title":"Am J Ophthalmol"},{"key":"345_CR39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","volume":"13","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux Y, Kodjikian L, Broussolle C, S\u00e8ve P. Sarcoidosis and uveitis. Autoimmun Rev. 2014;13:840\u20139.","journal-title":"Autoimmun Rev"},{"key":"345_CR40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/IAE.0b013e3181b773fc","volume":"30","author":"AD Birnbaum","year":"2010","unstructured":"Birnbaum AD, Huang W, Sahin O, Tessler HH, Goldstein DA. Ocular sarcoidosis misdiagnosed as primary intraocular lymphoma. Retina. 2010;30:310\u20136.","journal-title":"Retina"},{"key":"345_CR41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/08820538.2011.588654","volume":"26","author":"D Pan","year":"2011","unstructured":"Pan D, Hirose T. Vogt-Koyanagi-Harada syndrome: review of clinical features. Semin Ophthalmol. 2011;26:312\u20135.","journal-title":"Semin Ophthalmol"},{"key":"345_CR42","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.autrev.2014.01.023","volume":"13","author":"VM Sakata","year":"2014","unstructured":"Sakata VM, da Silva FT, Hirata CE, de Carvalho JF, Yamamoto JH. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev. 2014;13:550\u20135.","journal-title":"Autoimmun Rev"},{"key":"345_CR43","first-page":"533","volume":"76","author":"A Mohsenin","year":"2012","unstructured":"Mohsenin A, Huang JJ. Ocular manifestations of systemic inflammatory diseases. Conn Med. 2012;76:533\u201344.","journal-title":"Conn Med"},{"key":"345_CR44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajo.2008.08.019","volume":"147","author":"LL Lim","year":"2009","unstructured":"Lim LL, Scarborough JD, Thorne JE, et al. Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol. 2009;147:332\u20138.","journal-title":"Am J Ophthalmol"},{"key":"345_CR45","first-page":"284","volume":"6","author":"P Allegri","year":"2011","unstructured":"Allegri P, Rissotto R, Herbort CP, Murialdo U. CNS diseases and uveitis. J Ophthalmic Vis Res. 2011;6:284\u2013308.","journal-title":"J Ophthalmic Vis Res"},{"key":"345_CR46","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/ibd.21180","volume":"16","author":"DB Cury","year":"2010","unstructured":"Cury DB, Moss AC. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1393\u20136.","journal-title":"Inflamm Bowel Dis"},{"key":"345_CR47","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bjophthalmol-2011-301051","volume":"96","author":"K Mollazadegan","year":"2012","unstructured":"Mollazadegan K, Kugelberg M, Tallstedt L, Ludvigsson JF. Increased risk of uveitis in coeliac disease: a nationwide cohort study. Br J Ophthalmol. 2012;96:857\u201361.","journal-title":"Br J Ophthalmol"},{"key":"345_CR48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.icu.0000434534.32063.5c","volume":"24","author":"RS Moorthy","year":"2013","unstructured":"Moorthy RS, London NJ, Garg SJ, Cunningham ET Jr. Drug-induced uveitis. Curr Opin Ophthalmol. 2013;24:589\u201397.","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"345_CR49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1869-5760-3-43","volume":"25","author":"NJ London","year":"2013","unstructured":"London NJ, Garg SJ, Moorthy RS, Cunningham ET. Drug-induced uveitis. J Ophthalmic Inflamm Infect. 2013;25(3):43. doi: 10.1186\/1869-5760-3-43 .","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"1","key":"345_CR50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1517\/14740338.2015.972363","volume":"14","author":"M Cordero-Coma","year":"2015","unstructured":"Cordero-Coma M, Salazar-Mendez R, Garzo-Garcia I, et al. Drug-induced uveitis. Expert Opin Drug Saf. 2015;14(1):111\u201326.","journal-title":"Expert Opin Drug Saf"},{"key":"345_CR51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"345_CR52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/eye.2011.255","volume":"26","author":"RW Lee","year":"2012","unstructured":"Lee RW, Dick AD. Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye. 2012;26:17\u201328.","journal-title":"Eye"},{"key":"345_CR53","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/jir.2011.0042","volume":"31","author":"R Horai","year":"2011","unstructured":"Horai R, Caspi RR. Cytokines in autoimmune uveitis. J Interferon Cytokine Res. 2011;31:733\u201344.","journal-title":"J Interferon Cytokine Res"},{"key":"345_CR54","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1167\/iovs.05-1547","volume":"47","author":"S Sugita","year":"2006","unstructured":"Sugita S, Takase H, Taguchi C, et al. Ocular infiltrating CD4\u00a0+\u00a0T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Investig Ophthalmol Vis Sci. 2006;47:2547\u201354.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"345_CR55","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1167\/iovs.04-1273","volume":"46","author":"FM Damico","year":"2005","unstructured":"Damico FM, Cunha-Neto E, Goldberg AC, et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Investig Ophthalmol Vis Sci. 2005;46:2465\u201371.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"345_CR56","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-60761-720-4_22","volume":"900","author":"RK Agarwal","year":"2012","unstructured":"Agarwal RK, Silver PB, Caspi RR. Rodent models of experimental autoimmune uveitis. Methods Mol Biol. 2012;900:443\u201369.","journal-title":"Methods Mol Biol"},{"key":"345_CR57","doi-asserted-by":"crossref","first-page":"e29742","DOI":"10.1371\/journal.pone.0029742","volume":"7","author":"CR Yu","year":"2012","unstructured":"Yu CR, Lee YS, Mahdi RM, Surendran N, Egwuagu CE. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis. PLoS ONE. 2012;7:e29742.","journal-title":"PLoS ONE"},{"key":"345_CR58","first-page":"3486","volume":"17","author":"T Qin","year":"2011","unstructured":"Qin T. Upregulation of DR3 expression in CD4(+) T cells promotes secretion of IL-17 in experimental autoimmune uveitis. Mol Vis. 2011;17:3486\u201393.","journal-title":"Mol Vis"},{"key":"345_CR59","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/09273948.2013.815786","volume":"21","author":"S Jawad","year":"2013","unstructured":"Jawad S, Liu B, Agron E, Nussenblatt RB, Sen HN. Elevated serum levels of interleukin-17A in uveitis patients. Ocul Immunol Inflamm. 2013;21:434\u20139.","journal-title":"Ocul Immunol Inflamm"},{"key":"345_CR60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/intimm\/dxm135","volume":"20","author":"T Yoshimura","year":"2008","unstructured":"Yoshimura T, Sonoda KH, Miyazaki Y, et al. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol. 2008;20:209\u201314.","journal-title":"Int Immunol"},{"key":"345_CR61","first-page":"155","volume":"17","author":"RR Caspi","year":"2014","unstructured":"Caspi RR. Understanding autoimmunity in the eye: from animal models to novel therapies. Discov Med. 2014;17:155\u201362.","journal-title":"Discov Med"},{"key":"345_CR62","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1167\/iovs.03-1113","volume":"45","author":"JH Chang","year":"2004","unstructured":"Chang JH, McCluskey P, Wakefield D. Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Investig Ophthalmol Vis Sci. 2004;45:1871\u20138.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"345_CR63","first-page":"2970","volume":"17","author":"DS Pratap","year":"2011","unstructured":"Pratap DS, Lim LL, Wang JJ, et al. The role of toll-like receptor variants in acute anterior uveitis. Mol Vis. 2011;17:2970\u20137.","journal-title":"Mol Vis"},{"key":"345_CR64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/bjo.2005.072686","volume":"90","author":"JH Chang","year":"2006","unstructured":"Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol. 2006;90:103\u20138.","journal-title":"Br J Ophthalmol"},{"key":"345_CR65","first-page":"170","volume":"17","author":"J Wang","year":"2011","unstructured":"Wang J, Lu H, Hu X, et al. Nuclear factor translocation and acute anterior uveitis. Mol Vis. 2011;17:170\u20136.","journal-title":"Mol Vis"},{"key":"345_CR66","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20050429","volume":"203","author":"RS Grajewski","year":"2006","unstructured":"Grajewski RS, Silver PB, Agarwal RK, et al. Endogenous IRBP can be dispensable for generation of natural CD4+ CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J Exp Med. 2006;203:851\u20136.","journal-title":"J Exp Med"},{"key":"345_CR67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/bjo.2006.099192","volume":"91","author":"H Keino","year":"2007","unstructured":"Keino H, Takeuchi M, Usui Y, et al. Supplementation of CD4+ CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br J Ophthalmol. 2007;91:105\u201310.","journal-title":"Br J Ophthalmol"},{"key":"345_CR68","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/s10165-008-0064-x","volume":"18","author":"Y Nanke","year":"2008","unstructured":"Nanke Y, Kotake S, Goto M, Ujihara H, Matsubara M, Kamatani N. Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet\u2019s disease before ocular attack: a possible predictive marker of ocular attack. Mod Rheumatol. 2008;18:354\u20138.","journal-title":"Mod Rheumatol"},{"key":"345_CR69","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1167\/iovs.08-1793","volume":"49","author":"L Chen","year":"2008","unstructured":"Chen L, Yang P, Zhou H, et al. Diminished frequency and function of CD4\u00a0+\u00a0CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Investig Ophthalmol Vis Sci. 2008;49:3475\u201382.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"345_CR70","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1167\/iovs.09-3514","volume":"51","author":"M Sun","year":"2010","unstructured":"Sun M, Yang P, Du L, Zhou H, Ren X, Kijlstra A. Contribution of CD4+ CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis. Investig Ophthalmol Vis Sci. 2010;51:383\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"345_CR71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/09273948.2012.681830","volume":"20","author":"S Ruggieri","year":"2012","unstructured":"Ruggieri S, Frassanito MA, Dammacco R, Guerriero S. Treg lymphocytes in autoimmune uveitis. Ocul Immunol Inflamm. 2012;20:255\u201361.","journal-title":"Ocul Immunol Inflamm"},{"key":"345_CR72","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1074\/jbc.M110.197616","volume":"286","author":"B Manickam","year":"2011","unstructured":"Manickam B, Jha P, Matta B, Liu J, Bora PS, Bora NS. Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses. J Biol Chem. 2011;286:8472\u201380.","journal-title":"J Biol Chem"},{"key":"345_CR73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.molimm.2010.08.006","volume":"48","author":"B Manickam","year":"2010","unstructured":"Manickam B, Jha P, Hepburn NJ, et al. Suppression of complement activation by recombinant Crry inhibits experimental autoimmune anterior uveitis (EAAU). Mol Immunol. 2010;48:231\u20139.","journal-title":"Mol Immunol"},{"key":"345_CR74","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.exer.2005.07.011","volume":"82","author":"RW Read","year":"2006","unstructured":"Read RW, Szalai AJ, Vogt SD, McGwin G, Barnum SR. Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis. Exp Eye Res. 2006;82:389\u201394.","journal-title":"Exp Eye Res"},{"key":"345_CR75","first-page":"170","volume":"42","author":"AD Dick","year":"2001","unstructured":"Dick AD, Broderick C, Forrester JV, Wright GJ. Distribution of OX2 antigen and OX2 receptor within retina. Investig Ophthalmol Vis Sci. 2001;42:170\u20136.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"345_CR76","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2353\/ajpath.2007.070272","volume":"171","author":"DA Copland","year":"2007","unstructured":"Copland DA, Calder CJ, Raveney BJ, et al. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am J Pathol. 2007;171:580\u20138.","journal-title":"Am J Pathol"},{"key":"345_CR77","first-page":"1865","volume":"18","author":"MM Yang","year":"2012","unstructured":"Yang MM, Lai TY, Tam PO, et al. Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis. Mol Vis. 2012;18:1865\u201372.","journal-title":"Mol Vis"},{"key":"345_CR78","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1167\/iovs.12-9478","volume":"53","author":"MM Yang","year":"2012","unstructured":"Yang MM, Lai TY, Tam PO, et al. Association of C2 and CFB polymorphisms with anterior uveitis. Investig Ophthalmol Vis Sci. 2012;53:4969\u201374.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"345_CR79","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/clin.1993.1057","volume":"67","author":"SM Whitcup","year":"1993","unstructured":"Whitcup SM, DeBarge LR, Caspi RR, Harning R, Nussenblatt RB, Chan CC. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a\/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol. 1993;67:143\u201350.","journal-title":"Clin Immunol Immunopathol"},{"key":"345_CR80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-2567.1996.d01-666.x","volume":"88","author":"L Devine","year":"1996","unstructured":"Devine L, Lightman SL, Greenwood J. Role of LFA-1, ICAM-1, VLA-4 and VCAM-1 in lymphocyte migration across retinal pigment epithelial monolayers in vitro. Immunology. 1996;88:456\u201362.","journal-title":"Immunology"},{"key":"345_CR81","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1167\/iovs.04-0418","volume":"46","author":"AP Martin","year":"2005","unstructured":"Martin AP, de Moraes LV, Tadokoro CE, et al. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis. Investig Ophthalmol Vis Sci. 2005;46:2056\u201363.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"345_CR82","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1097-4547(19970801)49:3<268::AID-JNR2>3.0.CO;2-A","volume":"49","author":"JD Luna","year":"1997","unstructured":"Luna JD, Chan CC, Derevjanik NL, et al. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res. 1997;49:268\u201380.","journal-title":"J Neurosci Res"},{"key":"345_CR83","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000103239","volume":"39","author":"C Tappeiner","year":"2007","unstructured":"Tappeiner C, Heinz C, Specker C, Heiligenhaus A. Rituximab as a treatment option for refractory endogenous anterior uveitis. Ophthalmic Res. 2007;39:184\u20136.","journal-title":"Ophthalmic Res"},{"key":"345_CR84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1756-185X.2010.01546.x","volume":"13","author":"F Davatchi","year":"2010","unstructured":"Davatchi F, Shams H, Rezaipoor M, et al. Rituximab in intractable ocular lesions of Behcet\u2019s disease; randomized single-blind control study (pilot study). Int J Rheum Dis. 2010;13:246\u201352.","journal-title":"Int J Rheum Dis"},{"key":"345_CR85","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/rheumatology\/ker107","volume":"50","author":"A Heiligenhaus","year":"2011","unstructured":"Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology. 2011;50:1390\u20134.","journal-title":"Rheumatology"},{"key":"345_CR86","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/14728214.2011.537824","volume":"16","author":"T Larson","year":"2011","unstructured":"Larson T, Nussenblatt RB, Sen HN. Emerging drugs for uveitis. Expert Opin Emerg Drugs. 2011;16:309\u201322.","journal-title":"Expert Opin Emerg Drugs"},{"key":"345_CR87","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000336338","volume":"51","author":"BM Gomes","year":"2012","unstructured":"Gomes BM, Sepah YJ, Do DV, et al. New treatment options for noninfectious uveitis. Dev Ophthalmol. 2012;51:134\u201361.","journal-title":"Dev Ophthalmol"},{"key":"345_CR88","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","volume":"108","author":"CM Samson","year":"2001","unstructured":"Samson CM, Waheed N, Baltatzis S, Foster CS. Methotrexate therapy for chronic non-infectious uveitis: analysis of a case series of 160 patients. Ophthalmology. 2001;108:1134\u20139.","journal-title":"Ophthalmology"},{"key":"345_CR89","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ophtha.2003.08.034","volume":"111","author":"K Durrani","year":"2004","unstructured":"Durrani K, Papaliodis GN, Foster CS. Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety. Ophthalmology. 2004;111:960\u20135.","journal-title":"Ophthalmology"},{"key":"345_CR90","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","volume":"148","author":"S Pasadhika","year":"2009","unstructured":"Pasadhika S, Kempen JH, Newcomb CW, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148:500\u20139.","journal-title":"Am J Ophthalmol"},{"key":"345_CR91","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/eye.2008.174","volume":"23","author":"C Tappeiner","year":"2009","unstructured":"Tappeiner C, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye. 2009;23:1192\u20138.","journal-title":"Eye"},{"key":"345_CR92","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","volume":"116","author":"S Gangaputra","year":"2009","unstructured":"Gangaputra S, Newcomb CW, Liesegang TL, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116:2188\u201398.","journal-title":"Ophthalmology"},{"key":"345_CR93","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","volume":"117","author":"RO Kacmaz","year":"2010","unstructured":"Kacmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117:576\u201384.","journal-title":"Ophthalmology"},{"key":"345_CR94","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","volume":"117","author":"SS Pujari","year":"2010","unstructured":"Pujari SS, Kempen JH, Newcomb CW, et al. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010;117:356\u201365.","journal-title":"Ophthalmology"},{"key":"345_CR95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","volume":"149","author":"E Daniel","year":"2010","unstructured":"Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149:423\u201332.","journal-title":"Am J Ophthalmol"},{"key":"345_CR96","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.2009.173542","volume":"95","author":"JC Goebel","year":"2011","unstructured":"Goebel JC, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. Br J Ophthalmol. 2011;95:209\u201313.","journal-title":"Br J Ophthalmol"},{"key":"345_CR97","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/acr.20404","volume":"63","author":"G Simonini","year":"2011","unstructured":"Simonini G, Taddio A, Cattalini M, et al. Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res. 2011;63:612\u20138.","journal-title":"Arthritis Care Res"},{"key":"345_CR98","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archophthalmol.2011.2698","volume":"130","author":"AA Okada","year":"2012","unstructured":"Okada AA, Goto H, Ohno S, Mochizuki M. Multicenter study of infliximab for refractory uveoretinitis in Behcet disease. Arch Ophthalmol. 2012;130:592\u20138.","journal-title":"Arch Ophthalmol"},{"key":"345_CR99","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.ophtha.2012.02.018","volume":"119","author":"M D\u00edaz-Llopis","year":"2012","unstructured":"D\u00edaz-Llopis M, Salom D, Garcia-de-Vicu\u00f1a C, et al. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Ophthalmology. 2012;119:1575\u201381.","journal-title":"Ophthalmology"},{"key":"345_CR100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bjophthalmol-2011-301401","volume":"97","author":"BC Dobner","year":"2013","unstructured":"Dobner BC, Max R, Becker MD, et al. A three-centre experience with adalimumab for the treatment of non-infectious uveitis. Br J Ophthalmol. 2013;97:134\u20138.","journal-title":"Br J Ophthalmol"},{"key":"345_CR101","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1756-185X.12139","volume":"16","author":"F Davatchi","year":"2013","unstructured":"Davatchi F, Shams H, Shahram F, et al. Methotrexate in ocular manifestations of Behcet\u2019s disease: a longitudinal study up to 15\u00a0years. Int J Rheum Dis. 2013;16:568\u201377.","journal-title":"Int J Rheum Dis"},{"key":"345_CR102","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ophtha.2013.07.019","volume":"121","author":"JN Kruh","year":"2014","unstructured":"Kruh JN, Yang P, Suelves AM, Foster CS. Infliximab for the treatment of refractory noninfectious uveitis: a study of 88 patients with long-term follow-up. Ophthalmology. 2014;121:358\u201364.","journal-title":"Ophthalmology"},{"key":"345_CR103","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1871528111312010006","volume":"12","author":"R Gallego-Pinazo","year":"2013","unstructured":"Gallego-Pinazo R, Dolz-Marco R, Mart\u00ednez-Castillo S, Ar\u00e9valo JF, D\u00edaz-Llopis M. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis. Inflamm Allergy Drug Targets. 2013;12:38\u201345.","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"48","key":"345_CR104","first-page":"2013","volume":"3","author":"WB Yates","year":"2013","unstructured":"Yates WB, McCluskey PJ, Wakefield D. Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy? J Ophthalmic Inflamm Infect. 2013;3(48):2013. doi: 10.1186\/1869-5760-3-48 .","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"345_CR105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2415-13-18","volume":"13","author":"AK Denniston","year":"2013","unstructured":"Denniston AK, Dick AD. Systemic therapies for inflammatory eye disease: past, present and future. BMC Ophthalmol. 2013;13:18. doi: 10.1186\/1471-2415-13-18 .","journal-title":"BMC Ophthalmol."},{"key":"345_CR106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ophtha.2013.08.029","volume":"121","author":"P Lin","year":"2014","unstructured":"Lin P, Suhler EB, Rosenbaum JT. The future of uveitis treatment. Ophthalmology. 2014;121:365\u201376.","journal-title":"Ophthalmology"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-015-0345-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-015-0345-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-015-0345-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:55:45Z","timestamp":1566471345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-015-0345-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,28]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1007\/s10238-015-0345-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,28]]}}}